Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer

Patients’ perception of the financial impact of head and neck cancer and the relationship to health related quality of life

(2011) S.N. Rogers et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy

(2011) C. Pinto et al.   ONCOLOGIST

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

(2010) R. Mesía et al.   ANNALS OF ONCOLOGY

Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) V. Gregoire et al.   ANNALS OF ONCOLOGY

Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer

(2010) Hind Mrabti et al.   Journal of Cancer Research and Therapeutics

Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil

(2008) P. Pfeiffer et al.   ANNALS OF ONCOLOGY

Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxel

(2008) Orlando Guntinas-Lichius et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Head and neck cancer

(2008) Athanassios Argiris et al.   LANCET

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

(2008) Jan B. Vermorken et al.   NEW ENGLAND JOURNAL OF MEDICINE

Administration of Cetuximab Every 2 Weeks in the Treatment of Metastatic Colorectal Cancer: An Effective, More Convenient Alternative to Weekly Administration?

(2008) J. Tabernero et al.   ONCOLOGIST

Multidisciplinary Management of Locally Advanced SCCHN: Optimizing Treatment Outcomes

(2008) K. K. Ang   ONCOLOGIST

Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck

(2008) C Ko et al.   ORAL DISEASES